Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly?

Novo Nordisk just addressed a problem that has prevented some from taking these drugs.Investors generally buy pharmaceutical stocks to add an element of safety to their portfolios. People need their medicines regardless of the economic environment, and this fact ensures a level of stability and growth for pharma companies' earnings.In recent years, though, certain drugmakers also have delivered a significant amount of growth. And this is thanks to one particular product portfolio: weight loss drugs. Novo No ...